US Capitol Capsule: Once 'market failure,' orphan drugs ripe for investing
This article was originally published in Scrip
Executive Summary
Much has been made about the fact there are no drugs approved to treat Ebola or vaccines available to prevent the deadly disease, which has killed about 70% of those who have contracted it during the current outbreak in West Africa, or about 5,000 people.